Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Sham Efficacy in the Treatment of Overactive Bladder Syndrome: Results From the SUmiT Trial

Journal of Urology

Volumn 183, Issue 4, 2010, Pages 1438-1443

  Peters, Kenneth M ^a   Carrico, Donna J ^a   Perez Marrero, Ramon A ^c   Khan, Ansar U ^d   Wooldridge, Leslie S ^b   Davis, Gregory L ^e   MacDiarmid, Scott A ^a  

^a BEAUMONT HOSPITAL   (United States)

^b MERCY HEALTH PARTNERS   (United States)

^c Advanced Research Institute   (United States)

^d Urology Health Center   (United States)

^e Alliance Urology Specialists ^*

Author keywords

electric stimulation therapy; overactive; tibial nerve; urge; urinary bladder; urinary incontinence

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MICTURITION; MULTICENTER STUDY; NEEDLE; NERVE STIMULATION; NEUROMODULATION; NOCTURIA; OVERACTIVE BLADDER; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAFETY; SHAM PROCEDURE; SYMPTOM; TIBIAL NERVE; URINARY FREQUENCY; URINARY URGENCY;

AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; SYNDROME; TIBIAL NERVE; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION; URINARY BLADDER, OVERACTIVE;

EID: 77949295592     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.12.036     Document Type: Article

References (24)

1. Coyne K.S., Payne C., Bhattacharyya S.K., et al. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health 7 (2004) 455
2. Tyagi S., Thomas C.A., Hayashi Y., et al. The overactive bladder: epidemiology and morbidity. Urol Clin North Am 33 (2006) 433
3. Teleman P.M., Lidfeldt J., Nerbrand C., et al. Overactive bladder: prevalence, risk factors and relation to stress incontinence in middle-aged women. BJOG 111 (2004) 600
4. Dmochowski R.R., and Newman D.K. Impact of overactive bladder on women in the United States: results of a national survey. Curr Med Res Opin 23 (2007) 65
5. Peters K.M., Feber K.M., and Bennett R.C. Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial. Neurourol Urodyn 24 (2005) 643
6. van Kerrebroeck P.E., van Voskuilen A.C., and Heesakkers J.P. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 178 (2007) 2029
7. Peters K.M., MacDiarmid S.A., Wooldridge L.S., et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the Overactive Bladder Innovative Therapy Trial. J Urol 182 (2009) 1055
8. Cooperberg M.R., and Stoller M.L. Percutaneous neuromodulation. Urol Clin North Am 32 (2005) 71
9. Finazzi Agro E., Campagna A., and Sciobica F. Posterior tibial nerve stimulation: is the once-a-week protocol the best option?. Minerva Urol Nefrol 57 (2005) 119
10. van der Pal F, van Balken M and Heesakkers JP: Intensive percutaneous tibial nerve stimulation in the treatment of urge urinary incontinence does not increase the success rate. Presented at the joint meeting of the International Continence Society/International Urogynecological Association, Paris, France, August 25-27, 2004.
11. Govier F.E., Litwiller S., Nitti V., et al. Percutaneous afferent neuromodulation for the refractory overactive bladder: results of a multicenter study. J Urol 165 (2001) 1193
12. van Balken M.R., Vandoninck V., Gisolf K.W., et al. Posterior tibial nerve stimulation as neuromodulative treatment of lower urinary tract dysfunction. J Urol 166 (2001) 914
13. Vandoninck V., van Balken M.R., Finazzi Agro E., et al. Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn 22 (2003) 227
14. Vandoninck V., van Balken M.R., Finazzi Agro E., et al. Posterior tibial nerve stimulation in the treatment of urge incontinence. Neurourol Urodyn 22 (2003) 17
15. Vandoninck V., van Balken M.R., Finazzi Agro E., et al. Posterior tibial nerve stimulation in the treatment of idiopathic nonobstructive voiding dysfunction. Urology 61 (2003) 567
16. van Leeuwen J.H., Castro R., Busse M., et al. The placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms. Eur Urol 50 (2006) 440
17. Chapple C., van Kerrebroeck P., Tubaro A., et al. Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder. Eur Urol 52 (2007) 1204
18. Hassouna M.M., Siegel S.W., Nyeholt A.A., et al. Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J Urol 163 (2000) 1849
19. Peters K.M., Carrico D.J., and Burks F. Validation of a sham for percutaneous tibial nerve stimulation (PTNS). Neurourol Urodyn 28 (2009) 58
20. Peters K.M., Killinger K.A., Ibrahim I.A., et al. The relationship between subjective and objective assessments of sacral neuromodulation effectiveness in patients with urgency-frequency. Neurourol Urodyn 27 (2008) 775
21. Coyne K.S., Matza L.S., and Thompson C.L. The responsiveness of the Overactive Bladder Questionnaire (OAB-q). Qual Life Res 14 (2005) 849
22. ® Health Survey: Manual and Interpretation Guide (1996), Quality Metrics Incorporated, Lincoln, Rhode Island
23. ® PC Instructions for Use (package insert) (2006), Uroplasty, Inc, Minnetonka, Minnesota
24. MacDiarmid S.A., Peters K.M., Shobeiri S.A., et al. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol 183 (2010) 234